DE69312608D1 - Kainatebindende, menschliche CNS-Rezeptoren der EAA5-Familie - Google Patents

Kainatebindende, menschliche CNS-Rezeptoren der EAA5-Familie

Info

Publication number
DE69312608D1
DE69312608D1 DE69312608T DE69312608T DE69312608D1 DE 69312608 D1 DE69312608 D1 DE 69312608D1 DE 69312608 T DE69312608 T DE 69312608T DE 69312608 T DE69312608 T DE 69312608T DE 69312608 D1 DE69312608 D1 DE 69312608D1
Authority
DE
Germany
Prior art keywords
kainate
family
receptors
binding
eaa5
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69312608T
Other languages
English (en)
Other versions
DE69312608T2 (de
Inventor
Rajender Kamboj
Candace E Elliott
Stephen L Nutt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allelix Biopharmaceuticals Inc
Original Assignee
Allelix Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allelix Biopharmaceuticals Inc filed Critical Allelix Biopharmaceuticals Inc
Application granted granted Critical
Publication of DE69312608D1 publication Critical patent/DE69312608D1/de
Publication of DE69312608T2 publication Critical patent/DE69312608T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02BINTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00Other engines
    • F02B75/02Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DE69312608T 1992-09-17 1993-09-16 Kainatebindende, menschliche CNS-Rezeptoren der EAA5-Familie Expired - Fee Related DE69312608T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94521092A 1992-09-17 1992-09-17

Publications (2)

Publication Number Publication Date
DE69312608D1 true DE69312608D1 (de) 1997-09-04
DE69312608T2 DE69312608T2 (de) 1997-12-04

Family

ID=25482790

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69312608T Expired - Fee Related DE69312608T2 (de) 1992-09-17 1993-09-16 Kainatebindende, menschliche CNS-Rezeptoren der EAA5-Familie

Country Status (8)

Country Link
US (2) US6333161B1 (de)
EP (1) EP0588642B1 (de)
JP (1) JPH06205680A (de)
AT (1) ATE156188T1 (de)
CA (1) CA2105804C (de)
DE (1) DE69312608T2 (de)
DK (1) DK0588642T3 (de)
ES (1) ES2105122T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2316616A (en) * 1996-09-02 1998-03-04 Lilly Industries Ltd Modulation of GluR5 receptors in the hippocampus to treat psychiatric disorders
ES2172359B1 (es) * 1999-02-04 2003-11-01 Univ Pais Vasco Peptido capaz de inducir anticuerpos contra la subunidad ka1 de los receptores de kainato de mamiferos, anticuerpo policlonal contra dicha subunidad ka1 y un procedimiento para su obtencion.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2215986T3 (es) * 1989-10-27 2004-10-16 The Salk Institute For Biological Studies Composiciones receptoras de glutamato y metodos.
NZ240921A (en) 1990-12-12 1994-06-27 Zymogenetics Inc G protein coupled glutamate receptor (neurotransmitters), recombinant production
ATE191747T1 (de) * 1991-08-26 2000-04-15 Allelix Biopharma Menschlicher ka-1 rezeptor, rezeptor aus der eaa1-familie (excitatory amino acid) mit hoher affinität für kainat
EP0529995B1 (de) * 1991-08-27 2000-04-05 Allelix Biopharmaceuticals Inc. Menschlicher KA-2-Rezeptor, Rezeptor aus der EAA2-Familie (Excitatory Amino Acid) mit hoher Affinität für Kainat

Also Published As

Publication number Publication date
DE69312608T2 (de) 1997-12-04
CA2105804A1 (en) 1994-03-18
DK0588642T3 (da) 1997-09-22
ES2105122T3 (es) 1997-10-16
US6333161B1 (en) 2001-12-25
US6322999B1 (en) 2001-11-27
CA2105804C (en) 2003-04-29
EP0588642A1 (de) 1994-03-23
ATE156188T1 (de) 1997-08-15
JPH06205680A (ja) 1994-07-26
EP0588642B1 (de) 1997-07-30

Similar Documents

Publication Publication Date Title
ZA90944B (en) Compounds which are antagonists of excitatory amino acid receptors
ATE522610T1 (de) Menschliche, metabotrope glutamatrezeptor- subtypen (hmr6) und verwandte dns-verbindungen
MY131442A (en) Excitatory amino acid receptor antagonists
DK0617123T3 (da) Kainatbindende, humane CNS-receptorer af EAA3-familien
ES2055036T3 (es) Antagonistas tetrazolicos de receptores de aminoacidos excitadores.
DK0529994T3 (da) Human KA-1-receptor, en kaniat højaffinitetsreceptor af EAA1-familien (excitatoriske aminosyrer)
DE69312608D1 (de) Kainatebindende, menschliche CNS-Rezeptoren der EAA5-Familie
GR3033880T3 (en) Human KA-2 receptor, a kainate high affinity receptor of the EAA2 (Excitatory Amino Acid) family.
DK0578409T3 (da) Kainatbindende humane CNS-receptorer af EAA4-typen
DE69328060D1 (de) Angiotensin-II Typ-1 Rezeptor und dessen Herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee